UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$463M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$360M |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$345M |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$265M |
| 5 |
ConocoPhillips
COP
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.03B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$378M |
| 3 |
Microsoft
MSFT
|
+$293M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$239M |
| 5 |
UnitedHealth
UNH
|
+$206M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.86% |
| 2 | Healthcare | 14.95% |
| 3 | Financials | 12.1% |
| 4 | Consumer Discretionary | 10.74% |
| 5 | Communication Services | 7.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Kosmos Energy
KOS
$1.49B
| $3.1M | ﹤0.01% |
598,728
-488,075
| -45% | -$2.96M |
|
1327
Cactus
WHD
$5.7B
| $3.07M | ﹤0.01% |
79,957
-8,548
| -10% | -$343K |
|
1328
Astec Industries
ASTE
$991M
| $3.04M | ﹤0.01% |
97,622
-12,421
| -11% | -$505K |
|
|
OPI
1329
DELISTED
Office Properties Income Trust
OPI
| $3.04M | ﹤0.01% |
216,675
+2,693
| +1% | +$50.6K |
|
1330
Ameris Bancorp
ABCB
$5.88B
| $3.04M | ﹤0.01% |
68,041
-10,071
| -13% | -$462K |
|
1331
Sociedad Química y Minera de Chile
SQM
$20.8B
| $3.04M | ﹤0.01% |
33,500
| – | – |
|
1332
Evolent Health
EVH
$444M
| $3.04M | ﹤0.01% |
84,543
-25,979
| -24% | -$915K |
|
1333
Viavi Solutions
VIAV
$9.18B
| $3.04M | ﹤0.01% |
232,639
-8,918
| -4% | -$127K |
|
|
SFBS
1334
ServisFirst Bancshares
SFBS
$4.84B
| $3.03M | ﹤0.01% |
37,912
-12,085
| -24% | -$1.02M |
|
1335
Atlantic Union Bankshares
AUB
$5.95B
| $3.02M | ﹤0.01% |
99,522
-21,838
| -18% | -$736K |
|
1336
United Natural Foods
UNFI
$2.8B
| $3.02M | ﹤0.01% |
87,912
-18,259
| -17% | -$778K |
|
1337
Group 1 Automotive
GPI
$3.16B
| $3.01M | ﹤0.01% |
21,098
-4,847
| -19% | -$831K |
|
1338
iQIYI
IQ
$1.31B
| $3.01M | ﹤0.01% |
1,109,411
-113,559
| -9% | -$421K |
|
1339
Procore
PCOR
$8.84B
| $3.01M | ﹤0.01% |
60,761
+14,201
| +31% | +$763K |
|
1340
Nurix Therapeutics
NRIX
$2.69B
| $3M | ﹤0.01% |
230,592
-13,713
| -6% | -$217K |
|
1341
Clearway Energy Class C
CWEN
$6.78B
| $3M | ﹤0.01% |
94,322
-8,019
| -8% | -$295K |
|
1342
Fox Factory Holding Corp
FOXF
$882M
| $2.99M | ﹤0.01% |
37,831
-4,644
| -11% | -$430K |
|
|
UNIT
1343
Uniti Group
UNIT
$2.28B
| $2.98M | ﹤0.01% |
428,559
-63,289
| -13% | -$588K |
|
1344
Navient
NAVI
$796M
| $2.98M | ﹤0.01% |
202,694
-28,973
| -13% | -$442K |
|
1345
Korn Ferry
KFY
$4.25B
| $2.97M | ﹤0.01% |
63,218
-10,183
| -14% | -$602K |
|
1346
Adient
ADNT
$1.44B
| $2.96M | ﹤0.01% |
106,801
-23,926
| -18% | -$776K |
|
1347
Bread Financial
BFH
$4.38B
| $2.96M | ﹤0.01% |
94,216
-11,940
| -11% | -$468K |
|
1348
Community Bank
CBU
$3.37B
| $2.96M | ﹤0.01% |
49,270
-13,855
| -22% | -$912K |
|
|
PPBI
1349
DELISTED
Pacific Premier Bancorp
PPBI
| $2.96M | ﹤0.01% |
95,550
-10,095
| -10% | -$329K |
|
1350
Rambus
RMBS
$10.4B
| $2.95M | ﹤0.01% |
116,172
-20,468
| -15% | -$512K |
|
Similar funds
UBS AM's Q3 2022 Portfolio in Review
As of Q3 2022, UBS AM held 2,816 positions worth $178B, down 6.6% from $191B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
UBS AM's Q3 2022 filing shows 65 new, 702 increased, 1,679 reduced and 77 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M. The largest sale was Apple, an estimated $2.03B.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q3 2022 buy was iShares Core S&P Total US Stock Market ETF: 4,072,197 shares worth $324M.
- UBS AM added most to Accenture in Q3 2022, an estimated $463M increase.
- UBS AM's biggest Q3 2022 reduction was Apple, cutting an estimated $2.03B.
- UBS AM fully exited Vanguard Russell 1000 ETF in Q3 2022, selling an estimated $93.3M.
- UBS AM's ten largest holdings make up 21% of its $178B portfolio in Q3 2022.
- UBS AM opened 65 new positions and closed 77 in Q3 2022.
- UBS AM's portfolio value fell 6.6% quarter-over-quarter to $178B.
Based on UBS AM's 13F filing for Q3 2022, filed 14 Nov 2022.